Chinese Journal of Pharmacovigilance ›› 2024, Vol. 21 ›› Issue (11): 1306-1308.
DOI: 10.19803/j.1672-8629.20240492

Previous Articles     Next Articles

Two Cases of Ceftriaxone Sodium for Injection Induced Immune Hemolytic Anemia in Children

DING Yiqiang1, LYU Zhiying2, LIU Canghai3, WEN Qinqin1, FANG Xiaoping4,*   

  1. 1Department of Pharmacy, Xingguo Hospital Affiliated to Gannan Medical University, Xingguo Jiangxi 342400, China;
    2Department of Blood Transfusion, Xingguo Hospital Affiliated to Gannan Medical University, Xingguo Jiangxi 342400, China;
    3Department of Pediatric Intensive Care, Xingguo Hospital Affiliated to Gannan Medical University, Xingguo Jiangxi 342400, China;
    4Department of Pediatrics, Xingguo Hospital Affiliated to Gannan Medical University, Xingguo Jiangxi 342400, China
  • Received:2024-07-19 Online:2024-11-15 Published:2024-11-20

Abstract: Objective To explore the clinical characteristics and mechanism of adverse drug reactions caused by ceftriaxone in children with immune hemolytic anemia. Methods Two cases of ceftriaxone sodium induced adverse reactions in children with immune hemolytic anemia and the correlations with adverse reactions were analyzed. Results Correlation analysis showed that both cases of hemolytic anemia were caused by ceftriaxone sodium, which was immediately discontinued and the patients were discharged after blood transfusion and glucocorticoid treatment. Conclusion Clinicians should pay attention to the risk of adverse reactions of ceftriaxone-induced immune hemolytic anemia in clinical practice. Rapid identification and appropriate immunological diagnosis and treatment can facilitate the prognosis of patients.

Key words: Ceftriaxone, Immune Hemolytic Anemia, Abdominal Pain, Anaphylactic Shock, Adverse Drug Reaction, Anti-Ceftriaxone Antibody, Serological Test, Children

CLC Number: